Close Menu

NEW YORK — German diagnostics firm Epigenomics reported on Tuesday a 69 percent drop in its third quarter revenues amid lower product sales and licensing revenues.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.